Intergroupe Francophone de Cancerologie Thoracique
2 clinical trials · 2 recruiting · OTHER
Trials by Intergroupe Francophone de Cancerologie Thoracique
RECRUITINGPhase 3NCT06937905
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic...
Based on the efficacy of tarlatamab in patients with small-cell lung cancer, we aim to assess the efficacy of tarlatamab in patients with Advanced, pulmonary (large-cell only) or...
Sponsor: Intergroupe Francophone de Cancerologie ThoraciqueEnrolling: 12920 locations
Neuroendocrine Carcinoma
RECRUITINGPhase 2NCT06840834
Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After...
Multicentre, open-label, single arm phase II study for patients with PM previously treated by immunotherapy and standard chemotherapy. 38 patients will be given second or...
Sponsor: Intergroupe Francophone de Cancerologie ThoraciqueEnrolling: 3820 locations
Pleural Mesotheliomas